Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier.

× No keyword cloud information.

21 in total

1. Purification of human, dog and rabbit -fetoprotein by immunoadsorbents of sepharose coupled with anti-human -fetoprotein.

Authors: S Nishi; H Hirai
Journal: Biochim Biophys Acta Date: 1972-09-29

2. Effect of anti-alpha-fetoprotein serum on some cultured tumor cells.

Authors: Y Tsukada; M Mikuni; H Watabe; S Nishi; H Hirai
Journal: Int J Cancer Date: 1974-02-15 Impact factor: 7.396

3. In vitro cloning of a rat ascites hepatoma cell line, AH66, with special reference to alpha-fetoprotein synthesis.

Authors: Y Tsukada; M Mikuni; H Hirai
Journal: Int J Cancer Date: 1974-02-15 Impact factor: 7.396

4. Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors: G Mancini; A O Carbonara; J F Heremans
Journal: Immunochemistry Date: 1965-09

5. Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.

Authors: T Koji; N Ishii; T Munehisa; Y Kusumoto; S Nakamura; A Tamenishi; A Hara; K Kobayashi; Y Tsukada; S Nishi; H Hirai
Journal: Cancer Res Date: 1980-08 Impact factor: 12.701

6. alpha-Fetoprotein: studies of tumor-associated antigen cytotoxicity in mouse hepatoma BW7756.

Authors: G J Mizejewski; R P Allen
Journal: Clin Immunol Immunopathol Date: 1978-11

7. Production of alpha-fetoprotein and normal serum proteins by xenotransplanted human hepatomas in relation to their growth and morphology.

Authors: S Hirohashi; Y Shimosato; T Kameya; T Koide; T Mukojima; Y Taguchi; K Kageyama
Journal: Cancer Res Date: 1979-05 Impact factor: 12.701

8. Chemotherapy of human tumor xenografts in genetically athymic mice.

Authors: A A Ovejera; D P Houchens; A D Barker
Journal: Ann Clin Lab Sci Date: 1978 Jan-Feb Impact factor: 1.256

9. Evaluation of drug-antibody conjugates in the treatment of human myelosarcomas transplanted in nude mice.

Authors: Z A Latif; B B Lozzio; C J Wust; S Krauss; M C Aggio; C B Lozzio
Journal: Cancer Date: 1980-03-15 Impact factor: 6.860

10. Effect of horse antibody to rat alpha-fetoprotein upon the growth of AH-66 in Donryu rats.

Authors: H T Wepsic; Y Tsukada; N Takeichi; S Nishi; H Hirai
Journal: Int J Cancer Date: 1980-05-15 Impact factor: 7.396

3 in total

1. Evaluation of a conjugate of purified antibodies against human AFP-dextran-daunorubicin to human AFP-producing yolk sac tumor cell lines.

Authors: K Ohkawa; N Hibi; Y Tsukada
Journal: Cancer Immunol Immunother Date: 1986 Impact factor: 6.968

2. Selective in vitro and in vivo growth inhibition against human yolk sac tumor cell lines by purified antibody against human alpha-fetoprotein conjugated with mitomycin C via human serum albumin.

Authors: K Ohkawa; Y Tsukada; N Hibi; N Umemoto; T Hara
Journal: Cancer Immunol Immunother Date: 1986 Impact factor: 6.968

3. The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.

Authors: K Ohkawa; Y Tsukada; H Dohzono; K Koike; Y Terashima
Journal: Br J Cancer Date: 1988-07 Impact factor: 7.640

3 in total